Risk of Vitamin B12 Deficiency Associated with Proton Pump Inhibitors, Metformin, and H2 Blockers in Geriatric Patients: A Polypharmacy Perspective

Abstract Vitamin B12 deficiency is a prevalent but often underdiagnosed issue that occurs most commonly in geriatric patients. The clinical manifestations are often subtle; however, the potential for severe complications, particularly hematological or neuropsychiatric, warrants investigations of all patients who present with vitamin deficiency. This literature review investigates the risk of vitamin B12 deficiency associated with proton pump inhibitors (PPI), metformin, and H2 receptor antagonists through the lens of polypharmacy. These drugs are frequently prescribed to the elderly, and although they are useful in treating long-term illnesses like GERD, type 2 diabetes, and peptic ulcer disease, they often can interfere with the body's ability to absorb vitamin B12 through various physiological pathways. The purpose of this review is to determine the risk of vitamin B12 deficiency in older patients taking H2 blockers, PPIs, and metformin, as well as how polypharmacy affects this risk. In gathering information for this study, we searched PubMed, Scopus, and Google Scholar for articles published in the last 20 years. Articles that were not in English or did not have a clear methodological approach were not included in this study. Long-term use of all three drug classes was found to be significantly associated with lower serum vitamin B12 levels; metformin and PPI users exhibited a dose and duration-dependent pattern. Combining these medications raises the risk even further, and age-related physiological changes and supplement noncompliance can exacerbate vitamin B12 deficiency. These findings highlight the need for proactive B12 level monitoring for elderly patients on long-term medication regimens. This monitoring should include screening and tailored supplementation for any potential deficiencies. Improving overall patient outcomes and reducing the burden of complications resulting from deficiencies would be the goals.

Authors

Institutions

Publication Details

Journal
The Egyptian Journal of Internal Medicine
Published
2025-09-05
DOI
https://doi.org/10.1186/s43162-025-00516-8
Primary Topic
Folate and B Vitamins Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk of Vitamin B12 Deficiency Associated with Proton Pump Inhibitors, Metformin, and H2 Blockers in Geriatric Patients: A Polypharmacy Perspective

Jamaluddin Shaikh, Ibrahim Ahmed, Latifa Nabeel Alsaad, Maithem Al-Hamdani et al.
The Egyptian Journal of Internal Medicine
Folate and B Vitamins Research
article

Risk of Vitamin B12 Deficiency Associated with Proton Pump Inhibitors, Metformin, and H2 Blockers in Geriatric Patients: A Polypharmacy Perspective

Jamaluddin Shaikh, Ibrahim Ahmed, Latifa Nabeel Alsaad, Maithem Al-Hamdani, Amir Alshizawi, Ali Alhilo, Valerie Farag
article en

Abstract

Abstract Vitamin B12 deficiency is a prevalent but often underdiagnosed issue that occurs most commonly in geriatric patients. The clinical manifestations are often subtle; however, the potential for severe complications, particularly hematological or neuropsychiatric, warrants investigations of all patients who present with vitamin deficiency. This literature review investigates the risk of vitamin B12 deficiency associated with proton pump inhibitors (PPI), metformin, and H2 receptor antagonists through the lens of polypharmacy. These drugs are frequently prescribed to the elderly, and although they are useful in treating long-term illnesses like GERD, type 2 diabetes, and peptic ulcer disease, they often can interfere with the body's ability to absorb vitamin B12 through various physiological pathways. The purpose of this review is to determine the risk of vitamin B12 deficiency in older patients taking H2 blockers, PPIs, and metformin, as well as how polypharmacy affects this risk. In gathering information for this study, we searched PubMed, Scopus, and Google Scholar for articles published in the last 20 years. Articles that were not in English or did not have a clear methodological approach were not included in this study. Long-term use of all three drug classes was found to be significantly associated with lower serum vitamin B12 levels; metformin and PPI users exhibited a dose and duration-dependent pattern. Combining these medications raises the risk even further, and age-related physiological changes and supplement noncompliance can exacerbate vitamin B12 deficiency. These findings highlight the need for proactive B12 level monitoring for elderly patients on long-term medication regimens. This monitoring should include screening and tailored supplementation for any potential deficiencies. Improving overall patient outcomes and reducing the burden of complications resulting from deficiencies would be the goals.

The Egyptian Journal of Internal MedicineVol. 37(1)
Gulf Medical University (AE), Mohammed Bin Rashid University of Medicine and Health Sciences (AE)
Openalex Percentile: Top 65%
Folate and B Vitamins Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.